Resources Library

GET RESOURCE

Please provide the requested details below to download the document.

THE PRECISE (EUROPEAN) TRIAL - 2015

THE PRECISE (EUROPEAN) TRIAL - 2015

The PRECISE, 180-day clinical trial was performed at 7 clinical sites in Europe and included 71 participants with Type 1 and Type 2 diabetes. Results demonstrated the safety and accuracy of the Eversense under-the-skin CGM system and supported it as an alternative to transcutaneous CGM.

Related Resources

Infographic
EVERSENSE AT A GLANCE

Check out this graphic overview of the…

Interactive Module
FUNDAMENTALS OF CGM

Learn more about how continuous glucose…

Video
HOW TO GET STARTED

Get started with your new Eversense 90-day,…